I have a soup can from American Beauty chicken noddle condensed soup and in the ingredients it says contains a BIOENGINEERED FOOD INGREDIENT, Let’s find out what’s BIOENGINEERED FOOD INGREDIENT mean.

The “BIOENGINEERED FOOD INGREDIENT” label on the soup refers to an ingredient made from a genetically modified organism (GMO)—specifically, a crop or food source whose genetic material has been altered in a laboratory by inserting new genes to give it desirable traits such as resistance to pests or improved shelf life. This term is now used in the U.S. food industry to indicate compliance with federal law that requires disclosure of foods containing ingredients with detectable modified genetic material, which cannot be obtained through traditional breeding or naturally found in nature.

What Does It Mean?

Bioengineered food ingredient typically describes components like corn syrup, soy protein, canola oil, sugar derived from sugar beets, or other processed ingredients from crops that have been genetically engineered.
These ingredients are common in canned and processed foods, and have gone through modification to provide desired characteristics, such as resistance to bugs or drought.

Why Is It Labeled This Way?

The USDA requires foods with detectable modified genetic material to include this label so shoppers know if GMOs are present.
The label does not specify which ingredient is bioengineered, but the most common GMO crops used in processed foods are corn, soy, canola, and sugar beets.
Highly processed ingredients may have no remaining modified DNA and may not be labeled, but soup is likely labeled because one or more ingredients derive from such a crop.

Practical Example for Canned Soup

In condensed chicken noodle soup, likely candidates for bioengineered ingredients include corn syrup, oil (canola or soybean), or any starches or sweeteners from these sources.
Without seeing the full ingredient list, the exact ingredient cannot be determined, but it is almost always one of the above commonly modified crops.

Bioengineered ingredients are essentially GMO-derived components in food, labeled in accordance with U.S. disclosure laws to inform consumers about the presence of genetically engineered food sources.

What health dangers are there eating bioengineered foods ingredients?

The health risks associated with eating bioengineered (genetically modified) food ingredients are currently debated, with differing scientific perspectives:

Potential Health Concerns

Toxicity: Genetic engineering may cause genetic instability resulting in unintended toxic substances or increased natural toxins in the food. https://www.centerforfoodsafety.org/issues/311/ge-foods/ge-food-and-your-health
Allergic Reactions: New proteins introduced by genetic engineering could cause new allergies or transfer allergens from one food to another. https://pmc.ncbi.nlm.nih.gov/articles/PMC3791249/
Antibiotic Resistance: Some genetically engineered foods use antibiotic resistance markers that could potentially contribute to antibiotic-resistant bacteria in humans. https://www.centerforfoodsafety.org/issues/311/ge-foods/ge-food-and-your-health
Nutritional Changes: Genetic modifications may alter nutrient levels unpredictably, potentially reducing nutritional value or causing unknown effects. https://pubmed.ncbi.nlm.nih.gov/18989835/
Long-term Effects Uncertain: Unlike traditional foods, these foods have not been subject to extensive long-term human health testing. German Reference Centre for Ethics in the Life Scienceshttps://www.drze.de/en/research-publications/in-focus/genetically-modified-foods/modules/health-risks-by-modified-foods

Regulatory and Scientific Assessments

Major scientific bodies, including the World Health Organization (WHO) and the National Academies of Sciences, generally conclude that GMO foods currently on the market are no more risky to human health than conventional foods based on current evidence. https://www.who.int/news-room/questions-and-answers/item/food-genetically-modified
The U.S. FDA does not require mandatory pre-market safety testing of GMO foods, raising concerns about possible gaps in evaluation.
Some studies suggest potential risks, but overall consensus from regulatory agencies finds no reliable evidence linking approved GMO foods to adverse health effects.

In summary, while some scientific and advocacy groups warn of potential health risks from bioengineered foods, regulatory authorities and many scientific reviews find no conclusive evidence of harm in approved GMO foods currently on the market. Continued research and risk assessment remain important. https://www.fda.gov/media/135280/download

Didn’t the FDA Approve all COVID Vaccines as safe?

Yes, the FDA has approved several COVID-19 vaccines as safe for use, but the scope of approval has been evolving. As of 2025, the FDA has approved updated COVID-19 vaccines for specific populations such as adults 65 and older and individuals aged 5 through 64 who have underlying health conditions or are at high risk for severe COVID-19 outcomes. This is a shift from earlier broader authorizations that covered most age groups.

Previously, vaccines like those from Pfizer-BioNTech and Moderna were authorized for emergency use in broad age groups including children. However, emergency use authorizations (EUAs) for some have been revoked, and full FDA approvals now tend to focus on higher-risk groups in an effort to better match vaccines to circulating variants and current public health needs.

In summary, COVID-19 vaccines have undergone rigorous FDA approval processes and are considered safe for the groups they are approved for, but current FDA approvals may be limited to older adults and those with certain medical risks rather than blanket approval for the entire population.

Didn’t the WHO just get defunded by the Trump administration? What were the reasons for this defunding and complete separation of the USA from the WHO?

The Trump administration did initiate a formal withdrawal and defunding of the World Health Organization (WHO) starting in early 2025. Key reasons included accusations that WHO mismanaged the COVID-19 pandemic response, showed bias towards China, and lacked transparency. This was part of a broader policy agenda to reduce U.S. involvement and funding in international organizations considered to undermine U.S. national interests.

Specific actions included:

Termination of U.S. funding, which represented a significant portion of WHO’s budget.
An executive order on January 20, 2025, officially announcing U.S. withdrawal from WHO.
Broader cuts to global health programs and withdrawal from other UN agencies like UNESCO due to ideological and political motives.
Claims that WHO and related UN programs were involved in activities contrary to U.S. policy interests, such as reproductive health rights.
The defunding was part of an overall rollback of foreign aid and international cooperation programs, driven by conservative policy objectives emphasizing national sovereignty and budget austerity.

This U.S. exit caused a substantial funding shortfall for WHO and has had wide-reaching effects on global health initiatives, particularly affecting programs for women’s health, HIV/AIDS, and humanitarian assistance worldwide.

Timeline of US actions to cut WHO funding since 2025

Here is a timeline of key U.S. actions to cut WHO funding and withdraw since 2025:

January 20, 2025:President Trump signed Executive Order 14155 directing the formal withdrawal of the United States from the WHO. This began the process to stop funding and participation in the WHO.
January 20, 2025:Series of seven executive orders focused on realigning U.S. foreign aid and government spending, including orders to freeze foreign aid programs and reduce funding for international organizations like WHO.
January 21-24, 2025:Implementation of funding pauses and stop-work orders on existing foreign assistance awards through USAID, impacting global health programs funded by the U.S. and contributing to WHO financial shortfalls.
February 5, 2025:Additional executive memorandum to stop funding NGOs deemed contrary to national interests, further limiting support for global health programs linked to WHO and other international bodies.
February 2025:Legal challenges arose against cuts, including suits by state attorneys general and medical institutions blocking some NIH funding cuts related to global health, but WHO funding withdrawals continued.
Throughout 2025:Continued reductions in contributions, suspension of cooperative activities between U.S. health agencies like CDC and WHO personnel, and a reorientation of U.S. foreign aid and health policy away from WHO.

This timeline summarizes U.S. actions beginning with the January 2025 executive order withdrawal announcement and cascading through funding freezes, legal battles, suspension of collaboration, and overall realignment of foreign health aid away from WHO and related agencies.

Which executive orders ended US participation in WHO programs

The key executive orders issued by President Trump in 2025 that ended U.S. participation in WHO programs and initiated withdrawal include:

Executive Order 14155 (January 20, 2025): “Withdrawing The United States From The World Health Organization”
This order:
- Revoked President Biden’s 2021 letter retracting the original 2020 withdrawal notification.
- Revoked Executive Order 13987 (which created COVID-19 response coordination and strengthened WHO engagement).
- Directed U.S. government officials to pause transfers of funds, support, and resources to WHO.
- Ordered recalling and reassignment of U.S. personnel and contractors working with WHO.
- Directed cessation of U.S. negotiations on the WHO Pandemic Agreement and International Health Regulations amendments.
- Established new coordinating mechanisms within the National Security Council focused on U.S. public health and biosecurity independent of WHO.
Executive Order (February 5, 2025): “Withdrawing the United States from and Ending Funding to Certain United Nations Organizations”
This order extended the withdrawal to a broader group of UN agencies, effectively ending funding and participation in several international bodies including WHO.

These executive orders formalized the withdrawal, halted funding, ended collaboration, and directed U.S. government staff working with WHO to be reassigned. The one-year withdrawal period means full exit would take effect in early 2026.

Which agencies were directed to stop WHO collaboration and when?

The key U.S. agencies directed to stop collaboration with the World Health Organization (WHO) along with the timing are:

Centers for Disease Control and Prevention (CDC):
On January 26-28, 2025, the CDC was ordered by the White House to immediately halt all collaboration with WHO. This included stopping participation in technical working groups, advisory boards, cooperative agreements, and barring CDC staff from visiting WHO offices. This directive was implemented promptly following President Trump’s executive order to begin the WHO withdrawal process.
Department of Health and Human Services (HHS):
From around January 22, 2025, HHS staff were ordered to halt public communications broadly, including those related to WHO, pending further clearance. This was part of a wider freeze in external communications impacting health organizations closely tied to WHO collaboration.
Other federal health agencies (implied):
The executive orders and directives broadly instructed all U.S. government agencies with WHO involvement to recall personnel, end funding support, and stop cooperation, including coordination on technical and public health matters, effectively covering agencies beyond CDC and HHS.

These immediate halts began within days of the January 20, 2025 executive order withdrawal announcement and were crucial parts of ending U.S. collaboration with the WHO ahead of the formal one-year exit process.

The executive orders and directives broadly instructed all U.S. government agencies with WHO involvement to recall personnel, end funding support, and stop cooperation, including coordination on technical and public health matters, effectively covering agencies beyond CDC and HHS. Here’s the full list of all U.S. government agencies that have stopped dealing with the WHO.

The executive orders and directives broadly instructed a number of U.S. government agencies to end collaboration, recall personnel, and stop funding support with the WHO. While the most explicitly mentioned agencies are the CDC and HHS, other agencies involved with WHO programs were also affected, often implicitly through broad directives. Here is a list summarizing agencies known to have stopped dealing with WHO:

Centers for Disease Control and Prevention (CDC)
Immediate halt to all collaboration and communication with WHO in January 2025.
Department of Health and Human Services (HHS)
Stopped communications and WHO collaboration pending policy reviews in January 2025.
United States Agency for International Development (USAID)
Funding freezes and stop work orders affecting global health programs linked to WHO cooperation starting early 2025.
Office of the Secretary of State
Directed to pause fund transfers and recall personnel working with WHO.
Office of Management and Budget (OMB)
Instructed to pause funding transfers to WHO and oversee reassignment of personnel.
Office of Pandemic Preparedness and Response Policy (OPPR)
Replaced previous U.S. Global Health Security Strategy and assumed coordination functions previously involving WHO.
Other Federal Health and Research Agencies(implied)
Entities such as the National Institutes of Health (NIH), Food and Drug Administration (FDA), and other HHS sub-agencies likely curtailed activities integrating WHO guidance or participation due to the broad agency-wide freeze and personnel recalls.
Other International Cooperation and Foreign Affairs Agencies
Agencies involved in international health collaboration would have aligned with the executive orders to suspend WHO-related funding and cooperation, though specific names beyond the State Department are less detailed.

While the executive orders specifically name CDC, HHS, State, OMB, and OPPR in the administrative directives, the broad language and cascading effects imply that essentially all U.S. government agencies with WHO-related activities stopped formal cooperation and participation starting early 2025 pending full withdrawal.